Skip to main content
. 2023 Jun 13;5(7):354–363. doi: 10.1002/acr2.11571

Figure 2.

Figure 2

Proportion of patients experiencing a relapse (A) and number of relapse events (B) by type of relapse. *Relapse category selected without another relapse category defined. Relapse category selected with or without another relapse category defined; vasculitis relapse defined as BVAS of more than 0; asthma relapse defined as active asthma symptoms and/or signs with a corresponding worsening in ACQ‐6 score (compared with the most recent previous score); sino‐nasal relapse defined as active nasal and/or sinus disease, with corresponding worsening in one or more of the sino‐nasal symptom questions (compared with the most recent previous assessment). ACQ‐6, Asthma Control Questionnaire 6; BVAS, Birmingham Vasculitis Activity Score.